A phase I study of pembrolizumab in combination with enadenotucirev (EnAd) (SPICE) in subjects with metastatic or advanced carcinoma. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting ...
Infection with HPV16, a high-risk human papillomavirus (HPV), can cause cervical cancer in humans. These infections carry a high risk of morbidity and mortality globally in females. This study aimed ...
Background. This randomized, open trial compared regimens including 2 doses (2D) of human papillomavirus (HPV) 16/18 AS04-adjuvanted vaccine in girls aged 9-14 years with one including 3 doses (3D) in ...
The human papillomavirus infection is known to cause cervical cancer. The majority of human papillomavirus infections are harmless and typically clear spontaneously. However, persistent infection with ...
Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose Human papillomavirus (HPV) infections are suggested to be ...
Cervical cancer is the only malignancy associated with a single causative agent: human papillomavirus (HPV), and in particular the genotypes HPV-16 and HPV-18. Research by the HPV Vaccine Study group, ...
This is a preview. Log in through your library . Abstract Background: The elevated risk for incident head and neck cancer among human papillomavirus (HPV)-16-seropositive individuals has substantiated ...
An international team of researchers said Monday that receiving the human papillomavirus vaccine by age 16 reduces the risk ...
India Today on MSN
HPV vaccine proven to prevent cervical cancer, study confirms
Cervical cancer is the second most common cancer among Indian women. HPV vaccine, that costs approximately Rs 2,500, can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results